checkAd

     647  0 Kommentare US FDA Breakthrough Therapy Designation for Mushrooms Creating Big Opportunity - Seite 2

    "Our research team has collected scientific information, including biological and pharmacological studies related to the chemical constituents and curative effects of medicinal mushrooms from various journals in developing our mushroom formulas These herbs have been used in traditional Chinese and Ayurvedic medicine for thousands of years as food for optimum health," says Bhavna Solecki, VP, Research and Development at Flourish Mushroom Labs.

    Other related developments from around the markets include:

    HEXO Corporation (NYSE:HEXO) (TSX:HEXO) just launched Original Stash, its new value brand, in Ontario on Black Friday.  Adult-use consumers in Ontario will be able to purchase 28 grams (1 oz) of quality dried cannabis flower at black market prices, retailing at $140 ($5 per gram), including taxes. "HEXO is disrupting the black market this Black Friday," said Sebastien St-Louis, CEO and co-founder of HEXO. "We are committed to playing a valuable role in eliminating the illicit market and in protecting public health and safety. That's why we are pleased to continue rolling out Original Stash across Canada, providing consumers with a quality product at a low price. Our experience with the launch of Original Stash in October demonstrates that there is a strong demand for this type of product." HEXO is launching OS.220, the second dried flower product to roll out from the Original Stash brand, in Ontario. OS.220 is a mid-THC Indica flower blend of two strains, available in a 28 g (1 oz) format. The Ontario Cannabis Store is poised to make Original Stash available on its webstore and to all licensed retailers in the province, who can in turn choose to carry the brand. HEXO's Original Stash will be the first brand to be featured as part of the Ontario Cannabis Store's inaugural homepage holiday campaign, in conjunction with Black Friday. "Original Stash is providing consumers with 'quality weed at legit prices'," added St-Louis. "Consistent, reliable and controlled products like this can play a major role in achieving the goals we set out nationally by legalizing cannabis just over a year ago: eliminating the illicit market and protecting public health and safety. We look forward to continuing to work with our regulators and partners to deliver on those objectives."

    Seite 2 von 4



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    US FDA Breakthrough Therapy Designation for Mushrooms Creating Big Opportunity - Seite 2 Financialnewsmedia.com News Commentary PALM BEACH, Florida, Dec. 5, 2019 /PRNewswire/ - For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major …

    Schreibe Deinen Kommentar

    Disclaimer